Dimitra Tsavachidou, Ph.D.
Affiliations: | 2005 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Molecular BiologyGoogle:
"Dimitra Tsavachidou"Parents
Sign in to add mentor| Barbara L. Weber | grad student | 2005 | Penn | |
| (The role of Sprouty-dependent inhibition of the Ras /ERK pathway in melanoma cells: A systems biology approach.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen H, Fu T, Suh WK, et al. (2014) CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy. Cancer Immunology Research. 2: 167-76 |
| Gedye C, Kurban G, Gallie BL, et al. (2014) Surgical ischemia and detection of clear cell renal cell carcinoma biomarkers. Journal of Clinical Oncology. 32: e15571-e15571 |
| Chen H, Fu T, Tsavachidou D, et al. (2013) Abstract 1265: Sustained PI3-kinase signaling is mediated by ICOS, not CD28, for anti-tumor T-cell responses elicited by anti-CTLA-4. Cancer Research. 73: 1265-1265 |
| Guo H, Liu W, Ju Z, et al. (2012) An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays. Proteome Science. 10: 56 |
| Efstathiou E, Titus M, Tsavachidou D, et al. (2012) Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 637-43 |
| Efstathiou E, Troncoso P, Mohler J, et al. (2012) Abstract A2: A Study of the effects of MDV3100 in the tumor microenvironment of bone metastatic castrate resistant prostate cancer (bmCRPC) Cancer Research. 72 |
| Efstathiou E, Titus M, Tsavachidou D, et al. (2012) Abstract 2696: Modulation of intracrine androgen signaling in bone metastatic castrate resistant prostate cancer (bmCRPC) by MDV3100 Cancer Research. 72: 2696-2696 |
| Kurban G, Tsavachidou D, Gallie B, et al. (2012) Abstract 1278: Determining the proteomic changes that define progressor and non-progressor clear cell renal cell carcinoma Cancer Research. 72: 1278-1278 |
| Efstathiou E, Titus MA, Tsavachidou D, et al. (2011) MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: Apreliminary report. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4501 |
| Cheong JH, Park ES, Liang J, et al. (2011) Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Molecular Cancer Therapeutics. 10: 2350-62 |